(redirected from Coenzyme Q10)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.



(also benzoquinone, coenzyme Q), any of a series of derivatives of 5-methyl-2,3-dimethoxyquinone having a variable terpenoid side chain attached to the carbon atom in position six. Ubiquinones have from six to ten isoprenoid units (C5H8). The structural formula is

Ubiquinones figure in reactions that supply energy to cells. They are designated by the symbols UQn or CoQn; in the first, n represents the number of carbon atoms, and in the second, the number of isoprenoid units. For example, UQ30 will correspond to CoQ6. Ubiquinones occur as colorless, crystalline substances whose absorption maximum is at 270 micrometers. They are insoluble in water and soluble in organic solvents.

Ubiquinones are present in all organisms; UQ50 predominates in mammals, UQ30–50 in fungi, UQ40 in bacteria, UQ40–45 in protozoa, and UQ45–50 in insects. Plant mitochondria contain UQ40–50 in small quantities, and the chloroplasts in plants contain plastoquinones, which are similar to ubiquinones. Various naph-thoquinones occur in certain bacteria.

The biological role of ubiquinones is based on their ability to participate in reversible oxidation-reduction conversions. Ubiquinones are located in the cytoplasmic membranes of bacteria and in the inner membranes of mitochondria. They participate in the transfer of electrons and hydrogen between flavoproteins and cytochrome b in the respiratory chain.


Skulachev, V. P. Transformatsiia energii v biomembranakh. Moscow, 1972.
Morton, R. A. “Ubiquinones, Plastoquinones, and Vitamins K.” Biological Reviews of the Cambridge Philosophical Society, 1971, vol. 46, no. 1.


References in periodicals archive ?
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
The role of coenzyme Q10 in statin associated myopathy: a systematic review.
Gotz ME, Gerstner A, Harth R, Dirry A, Janetzky B, Kuhn W, Riederer P, Gerlach M, 2000, Altered redox state of platet coenzyme Q10 in Parkinson's disease.
Coenzyme Q10 is a component of the electron transport chain in mitochondria which is linked to the generation of energy in the cell.
Coenzyme Q10 has been a subject of research since 1957 (Crane, 1957).
Other studies have showed low heart levels of coenzyme Q10 in patients with heart muscle disease.
Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension (Southern Medical Journal, Nov 2001): Twice daily administration of 60 mg of oral CoQ-10 was given to 46 men and 37 women with isolated systolic hypertension in a 12-week randomized, double-blind, placebo-controlled trial.
Coenzyme Q10 (CoQ10) is a widely used and expensive supplement however its absorption rate from the intestine is low.
The American Heart Association notes that the safety and efficacy of CoQ10 require further study, and the organization "cannot recommend taking coenzyme Q10 regularly.
The global market for coenzyme Q10 reached a crest in 2004 and 2005, with demand outstripping supply worldwide.
Promising data with coenzyme Q10 shows that we might be able to support mitochondrial health to help prevent Parkinson's disease.